Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Naproxen- and sumatriptan-containing product in oral dose form | Has active ingredient | Naproxen (substance) | true | Inferred relationship | Some | 1 | |
| Naproxen- and sumatriptan-containing product in oral dose form | Is a | Naproxen-containing product in oral dose form | true | Inferred relationship | Some | ||
| Naproxen- and sumatriptan-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Naproxen- and sumatriptan-containing product in oral dose form | Is a | Product containing naproxen and sumatriptan (medicinal product) | true | Inferred relationship | Some | ||
| Naproxen- and sumatriptan-containing product in oral dose form | Has active ingredient | Sumatriptan (substance) | true | Inferred relationship | Some | 2 | |
| Naproxen- and sumatriptan-containing product in oral dose form | Is a | Sumatriptan-containing product in oral dose form | true | Inferred relationship | Some | ||
| Naproxen- and sumatriptan-containing product in oral dose form | Plays role | Antimigraine therapeutic role (role) | true | Inferred relationship | Some | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Naproxen- and sumatriptan-containing product in oral dose form | Inferred relationship | Some | |
| Naproxen and sumatriptan only product in oral dose form | Is a | True | Naproxen- and sumatriptan-containing product in oral dose form | Inferred relationship | Some | 
This concept is not in any reference sets